AIM
CVS icon

Advantage Investment Management’s CVS Health CVS Stock Holding History

Advantage Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$235K Buy
3,727
+1,318
+55% +$78.1K 0.18% 121
2019
Q2 		$131K Sell
2,409
-1,007
-29% -$54.2K 0.1% 194
2019
Q1 		$184K Sell
3,416
-117
-3% -$7.22K 0.14% 152
2018
Q4 		$231K Buy
3,533
+1,370
+63% +$102K 0.17% 97
2018
Q3 		$170K Buy
2,163
+940
+77% +$67.2K 0.11% 153
2018
Q2 		$79K Sell
1,223
-98
-7% -$6.46K 0.06% 291
2018
Q1 		$82K Buy
1,321
+117
+10% +$8.39K 0.03% 305
2017
Q4 		$87K Sell
1,204
-260
-18% -$18.9K 0.03% 312
2017
Q3 		$119K Buy
1,464
+637
+77% +$50.4K 0.04% 225
2017
Q2 		$67K Sell
827
-9,581
-92% -$757K 0.02% 300
2017
Q1 		$817K Buy
10,408
+9,891
+1,913% +$790K 0.32% 73
2016
Q4 		$41K Sell
517
-585
-53% -$47.3K 0.02% 371
2016
Q3 		$98K Sell
1,102
-791
-42% -$74.7K 0.04% 220
2016
Q2 		$181K Buy
1,893
+70
+4% +$6.98K 0.09% 141
2016
Q1 		$189K Sell
1,823
-17
-0.9% -$1.65K 0.08% 131
2015
Q4 		$180K Sell
1,840
-427
-19% -$41.8K 0.09% 145
2015
Q3 		$219K Sell
2,267
-46
-2% -$4.84K 0.13% 115
2015
Q2 		$243K Buy
2,313
+641
+38% +$65.5K 0.12% 128
2015
Q1 		$173K Sell
1,672
-75
-4% -$7.59K 0.1% 155
2014
Q4 		$168K Buy
+1,747
New +$154K 0.13% 137

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advantage Investment Management's CVS Position: Q3 2019 in Review

Advantage Investment Management increased its CVS Health (CVS) stake by 55% in Q3 2019, buying an estimated $78.1K and bringing the position to 3,727 shares worth $235K. The position accounts for 0.18% of the portfolio, ranked #121.

Advantage Investment Management first reported a position in CVS in Q4 2014 and has held it in 20 quarters since. The position peaked at $817K in Q1 2017. 1,683 funds tracked by Wall St. Rank hold CVS as of Q3 2019.

  • Advantage Investment Management held 3,727 shares of CVS Health worth $235K as of Q3 2019.
  • Advantage Investment Management bought 1,318 CVS Health shares in Q3 2019, an estimated $78.1K.
  • CVS Health made up 0.18% of Advantage Investment Management's portfolio in Q3 2019, its #121 holding.
  • Advantage Investment Management first reported a position in CVS Health in Q4 2014 and has held it in 20 quarters since.
  • Advantage Investment Management's CVS Health position peaked at $817K in Q1 2017.
  • 1,683 funds tracked by Wall St. Rank held CVS Health as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.